Deal & Cases
16. March 2021
Signing of a large investment (approx. CHF 40M) in a Series B financing in connection with a therapeutic company treating fibrotic disease.
Jacquemoud Stanislas represented the lead investor, which is a US based venture capital fund.
The team included Philippe Jacquemoud and Aurélie Guex-Crosier